| Logo | Name | Σ | Employees |
|---|---|---|---|
 | Rahko Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/ 73 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 |
 |  Pancreatic Cancer UK Together we’ll transform the future of pancreatic cancer. https://www.pancreaticcancer.org.uk/ We bring more breakthroughs through research, more change through campaigning, and more support through our expert nurses. Because people with pancreatic cancer need more than hope. Pancreatic Cancer Support, Pancreatic Cancer Research Funding, Awareness Raising, and Political Campaigning Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 3 | 141 |
 |  MedFacts Drug discovery with cutting-edge AI technology We’re pioneering the use of AI and shaping the future in drug discovery, significantly cutting costs and development times. Our unique AI algorithms have generated novel drug candidates and identified enhancements for existing therapies more efficiently than traditional methods, setting us apart in the competitive landscape. Artificial Intelligence, Data Science, Health, Medicines, and Drug development 141 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 |  Alesta Therapeutics Oral small molecules for rare diseases Alesta Therapeutics is a pioneering company based in Leiden, Netherlands, dedicated to the development of first-in-class small molecules that target GCN2. Our commitment to advanced, high-quality chemistry has led us to develop a clinical candidate with an extensive pre-GLP toxicology and CMC package. 137 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 10 |
 | Keltic Pharma Therapeutics The KELTICPharma team combine academic innovation, deep target knowledge and corporate drug discovery expertise. In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic. 106 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 11 |
 | LIMATICA Limatica develops a non-invasive solution for rapid quality assessment of batteries, focusing on intrinsic cell activity Limatica will bring depth into battery cell quality. With a patent-pending, ultra high resolution hardware device and a patented method to understand the intrinsic activity of battery cells, we will - Accelerate battery cell production - Enable detailed characterization between battery cells - Enhance Data Models for battery cell development & quality assessment Limatica is alumnus of XPRENEURS, Start-up of the year in Saxony (Top3), Top 50 EU startups in sustainable mobility and winner of the AI Award of Auto Motor Sport. Co-funded by … 17 similar entities Type: Startup Activities: deeptech biotech Technologies: Batteries Synthetic Biology | 5 | 8 |
 | Graph Therapeutics Improving the lives of patients with immune-mediated diseases through Al-driven precision medicine Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this. 26 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 12 |
 | PeptiSystems AB A new generation of flow-through instruments for solid-phase synthesis of peptide and oligonucleotide therapeutics. PeptiSystems offers a new generation of flow-through instruments for solid-phase peptide and oligonucleotide therapeutics synthesis. Based on flow-through column technology, our instruments are used within the biopharmaceutical and biotech industry for process development and large-scale GMP and non-GMP manufacturing. Chemistry first - our instruments are designed from a chemistry perspective to give maximum flexibility and control without compromise. Peptide Synthesis, Oligonucleotide Synthesis, Flowthrough column technology, Continuous flow, Organic chemistry, and Synthesis instruments Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 13 |
 | Umecrine Cognition AB A novel and safe approach for treating cognitive disorders Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness. The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy. The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 12 |
 | VeonGen Therapeutics GmbH Dedicated to develop the medicines of the future ViGeneron was founded in 2017 as a spin-off of the Ludwig-Maximilians-University (LMU) Munich. At ViGeneron we are dedicated to develop innovative gene therapies based on our two unique and proprietary technology platforms. ViGeneron will leverage its two technology platforms to address unmet medical needs with in-house gene therapy programs for selected retinal disorders. Together with partners we will exploit our ViGeneron technologies for additional indications. Gene Therapy, Inherited Retinal Disorders, and AAV vector 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 9 |
 | SciBase Pioneering prediction and prevention in dermatology SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops, manufactures and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs. Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements. The company has been on the Nasdaq … | 0 | 45 |
 | PreComb AI-guided Functional Precision Medicine PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwinTM technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome. Oncology, Combination therapies, Biotechnology, 3D tissue culture, Precision medicine, Drug profiling, Healthcare, Cancer therapy, Medtech, Life science, AI, and Personalized oncology 132 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I. | 5 | 13 |
 | Neumirna Therapeutics Targeting the Source. Transforming the Outcome. Our mission is to create a future where patients with neurological diseases are effectively treated. We are committed to unlocking the full potential of miRNA therapy as a new frontier in the treatment of neurological diseases. With diligence and creativity, we advance promising therapies that harness the power of miRNA biology to effectively treat diseases such as Epilepsy and Parkinson’s. Building on this commitment, we engage with patients, caregivers and the medical community to ensure we’re working towards outcomes that are truly life changing. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 17 |
 | Aptorum Group Limited (Nasdaq: APM) Facilitate life science innovations to tackle unmet medical needs. At Aptorum, we believe that by facilitating the development of medical innovations, particularly in those that able to meet current unmet medical needs and significantly improve clinical and surgical experience, is inevitable in advancing the quality of human life and patient care. With this vision, Mr. Ian Huen founded Aptorum, leveraging talented specialists and prosperous medical resources across the globe, to accelerate the evolution of potentially First-in-Class/Best-in-Class therapeutic and diagnostic innovations across a wide range of disease areas. By combining a broad pipeline of early stage novel medical innovations and multi-disciplinary … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech | 0 | 14 |
 | RayBiotech #Biotech company offering #proteomics detection tools since 2001. #Research news, promos, & blogs. #Biomarkers #CRO RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service. Protein Immunoassays, ELISA Kits, Antibody Arrays, Glycoscience, Protein Arrays, Immunological Assays, Antibody Development, Assay Development, Custom Protein Expression, Statistical Analysis, CRO Services, Flow cytometry, Recombinant proteins, Aptamers, Phosphorylation, Biostatistics, and Bioinformatics 63 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 61 |
 | Xeris Pharmaceuticals, Inc. We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 401 |
 | ZYTO ZYTO empowers personal wellness through technology, education, and application. ZYTO was founded by its Chairman Dr. Vaughn R Cook. The company designs and builds computer technology to facilitate decision-making about health and wellness. ZYTO’s product mix includes software and hardware sold to healthcare professionals, network marketers, and consumers. The innovative ZYTO scan technology facilitates an interface between a computer and the human body. The resulting dynamic data exchange, known as a biosurvey, involves computer-generated signatures called “Virtual Items” and recording the body’s galvanic skin response, a well-developed method of monitoring stress responses that is commonly used in applications like polygraph … Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 0 | 54 |
 | Enthought Transforming scientific R&D with strategy-led, purpose-built AI solutions. Enthought solves complex data challenges with AI and ML-driven solutions for enterprise scientific R&D organizations in the materials science, chemistry, semiconductor, life science, and energy industries. We develop purpose-built applications and solutions built to protect your IP, leverage your proprietary data, and fuel growth and innovation. AI and computational science is not new to Enthought. We've been at the intersection of science and AI/ML for over 20 years. Enthought was founded in 2001 by Eric Jones, PhD, often called the father of Scientific Python. We've seen and done a lot in the … 8 similar entities Type: SMB Activities: deeptech biotech consulting Technologies: A.I. A.I. - Deep Learning A.I. - Machine Learning Semiconductors | 1 | 70 |
 | FUJIFILM Cellular Dynamics, Inc The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy. Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development. induced pluripotent stem cells (iPS cells), human tissue cells, cardiomyocytes, endothelial cells, custom iPS cell lines, neurons, dopaminergic neurons, skeletal myoblasts, hepatocytes, hematopoietic progenitor cells, cardiac progenitor cells, and astrocytes 61 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 219 |
 | Bionano Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research. Bionano also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through our Bionano Laboratories business, wey also offer OGM-based diagnostic testing services. Genome Mapping, De Novo Assembly, Structural Variation, Single-Molecule … 31 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 5 | 176 |
 | Mon Health Enhancing the health of our communities through clinical excellence. Compassionate care. Employer of choice. Leaders in education & training – enhancing the health of our communities through clinical excellence. Vandalia Health Mon includes the following, as well as several affiliates – Vandalia Health Mon Medical Center; Vandalia Health Preston Memorial Hospital; Vandalia Health Stonewall Jackson Memorial Hospital; & Vandalia Health Mon Marion Neighborhood Hospital. Cancer Care, Women's Services, Diabetes Care, Emergency / Trauma Care, Heart Care / Cardiac Care, Home Care, Orthopedics, Pulmonary Care, Surgical Services, Diagnostic Services, Treatment Services, nursing, and hospital 18 similar entities Type: SMB Activities: healthtech biotech deeptech | 0 | 995 |
 | Illinois Biotechnology Innovation Organization (iBIO) To promote, connect and engage the life sciences community The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers. We drive industry growth by creating a forum for the life sciences community to come together, educating the public and policy makers, influencing public policy and advancing the economic interests of the community. iBIO’s members range from small startups to global corporations. They work in the … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech healthtech Technologies: Decarbonization | 10 | 8 |
 | Oakland Veterinary Referral Services 24-Hour Emergency & Specialty Care for Special Pets in Southeastern Michigan Oakland Veterinary Referral Services (OVRS) is a leading center for specialty veterinary care in the Midwest. Our locally owned and operated multi-specialty veterinary center is housed in one of the best-equipped animal care centers in the country. From referring veterinarians in search of specialty care to pet owners looking for top specialty or emergency services, OVRS is ready to help. We have a team of board-certified specialty veterians, each with advanced training in each of their specialty areas. They are backed by a highly trained support staff, and a … 16 similar entities Type: SMB Activities: pettech healthtech biotech deeptech | 1 | 105 |
 | Encephalon Inc. Encephalon Inc. is the parent company for Dr Joe Dispenza – New York Times best-selling author, researcher, lecturer, and corporate consultant neuroscience, chiropractic, author, lecturer, health, wellbeing, mind, body, soul, data, research, and science 61 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Data Analytics | 1 | 53 |
 | IEEE Engineering Medicine and Biology Society Your Global Connection to the Biomedical Engineering Community IEEE Engineering in Medicine and Biology Society (EMBS) is the world's largest international society of biomedical engineers. The organization's 12,000+ members reside in some 97 countries around the world. EMBS provides its members with access to the people, practices, information, ideas and opinions that are shaping one of the fastest growing fields in science. EMBS members come from everywhere and every walk of life. They work in industry, academic institutions, hospitals, entrepreneurs and government agencies. They design the electrical circuits that make a pacemaker run...create the software that reads an MRI...and help … Type: SMB Activities: deeptech biotech healthtech nanotech Technologies: Robotics Wireless | 4 | 146 |
 | Biodesix, Inc. Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2025 & 2024 Top Workplaces Award Winner Biodesix is a leading diagnostics solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. Our culture: The foundation of Biodesix workplace culture is based on these operating principles: TEAM. IMPACT. EXCELLENCE. Based on anonymous team member … 92 similar entities Type: SMB Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 4 | 279 |
 | Denterlein Standing with our clients at the intersection of business, communications & public policy. We are an independent public relations agency that inspires and influences the people you care about most. Our campaigns help boost integrity and loyalty, edge out the competition, manage your risk and build support for your vision. We craft tailored strategies to amplify your reach and engage the right audiences at the right time. From traditional press to powerful content and digital campaigns, we make your voice heard. Your company is only as strong as its reputation. We also help organizations prepare for and weather crisis events … 97 similar entities Type: SMB Activities: martech biotech edtech govtech healthtech proptech consulting deeptech | 3 | 28 |
 | LaVoieHealthScience Team of specialized thinkers and executors in health and science innovation. Global Alliance with Omnicom PR Group LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries. We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations … Type: Media SMB Activities: healthtech consulting deeptech biotech | 5 | 11 |
 | Parkinson's Institute and Clinical Center The mission of the Parkinson’s Institute and Clinical Center is to provide comprehensive patient care, while discovering new treatment options to improve the quality of life for all Parkinson’s disease (PD) patients. As America’s only independent non-profit organization combining research and patient care for PD under one roof, we are committed to changing the landscape of movement disorder treatment and research. Since its founding, Parkinson's Institute has helped thousands of PD patients better manage their disease, developed new treatments for PD, and published groundbreaking research aimed to close the gap between science and practical care. By focusing on all three … Type: SMB Activities: healthtech biotech deeptech | 1 | 17 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences 197 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 17 |
 | Instruct-ERIC Offering access to structural biology infrastructure to researchers in Europe and the World Instruct-ERIC is a pan-European distributed research infrastructure making high-end technologies and methods in structural biology available to users. Our aim is to promote innovation in biomedical science and operates on a non-economic basis within the scope of the ERIC Regulation. Instruct-ERIC is comprised of 17 Member Countries: Belgium, Czech Republic, EMBL, Finland, France, Germany, Greece, Israel, Italy, Latvia, Lithuania, Netherlands, Portugal, Slovakia, Slovenia, Spain and United Kingdom. Instruct-ERIC provides open access to cutting edge structural biology, specifically supporting research that uses integrated approaches and technologies. It operates … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 16 | 19 |
 | Better Better data, better care. Better has been transforming healthcare with the market-leading digital health platform, electronic prescribing and medication administration solution, and low-code tools that help healthcare organisations to rapidly build applications that suit their specific needs. We focus on simplifying the work of health and care teams. We build personalised digital applications and accelerate digitalisation by using low-code development tools. We advocate for data for life and strive for all health data to be vendor-neutral and easily accessible. Better has provided solutions across more than 20 markets, and Better Platform securely supports over 30 million patients. Better has offices … 42 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics | 14 | 159 |
 | RaySearch Laboratories Advancing Cancer Treatment ADVANCING CANCER TREATMENT RaySearch is advancing cancer treatment through pioneering software. Software has unlimited potential, and we believe it is now the driving force for innovation in oncology. Medical science never stands still, and neither does RaySearch. We work in close cooperation with leading cancer centers to bring scientific advancements faster to the clinical world. Today, our solutions support thousands of clinics worldwide in the fight against cancer. And this is just the beginning. software, radiation therapy, optimization, usability engineering, cancer care, Oncology Information Systems, cancer treatment, and Treatment planning systems 9 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: SaaS | 3 | 406 |
 | MSD Sverige MSD Sveriges officiella LinkedIn. Om oss: http://www.msd.se/om-oss/ Frågor om MSD läkemedel: medicinskinfo@msd.com. Biverkansrapportering: pv.sweden@msd.com. Oncology, Diabetes, Hospital Specialty Care, Cardiovascular, Vaccines, and Kvinnohälsa 7 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 96 |
 | NDA Group - an SSI Strategy Company Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is … 120 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 120 |
 | La Roche-Posay Laboratoire Dermatologique LIFE-CHANGING SKINCARE PRESCRIBED BY DERMATOLOGISTS At La Roche-Posay, we know skin is a matter of life. While skin issues can scar our lives in more ways than one, healing skin has the power to change lives in more ways than one. Everyday, we drive dermatology forward by joining forces with the medical community. Together, we pioneer new ways to be at the service of people. By bringing together radical efficacy and profound human understanding. By revealing the life impact of skin issues, one study at a time, to broaden the scope of care. By bringing the most advanced dermatological knowledge … | 7 | 333 |
 | Institut NeuroMyogène The Institut NeuroMyoGène (INMG) is a novel institute dedicated to the study of the nervous and muscular systems. It was created in 2016 in Lyon at the heart of a dense hospital network and of one of the biggest medical universities in France. The INMG goal is to unravel fundamental aspects of the cell biology of the muscle and nervous system from development to aging under normal and pathological conditions. Using a variety of invertebrate and vertebrate model systems, the INMG is conducting an integrated multidisciplinary research from gene to physiological functions. One of its priorities is to develop relevant … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 4 | 115 |
 | Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … 100 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 77 |
 | CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: SMB Activities: biotech deeptech healthtech cosmetics Technologies: Synthetic Biology | 12 | 2 |
 | BRIC-BoRdeaux Institute of onCology Cliniciens et chercheurs réunis à Bordeaux pour la recherche contre le cancer. Unité de recherche sous les tutelles Inserm et Université de Bordeaux, composée de 11 équipes de recherche sur la thématique cancer : Team A. Bikfalvi / L. Brisson / T. Mathivet Tumor and vascular biology laboratory. Team M. Khatib / F. Delom Reprogramming tumor activity and associated microenvironment (RYTME). Team V. Moreau / F. Saltel Liver cancers and tumor invasion (LCTI). Team C. Varon Helicobacter- associated digestive cancers, cancers stem cells and therapeutic strategies. Team H. Rezvani / M. Beylot Barry Translational Research in Oncodermatology and orphan skin … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 30 | 90 |
 | Laboratoires URGO A French company in Family Capital, URGO laboratories are responsible for identifying the care and health needs of consumers and patients and providing innovative responses from their technological and scientific know-how. Urgo laboratories are among the laboratories recognized both by the general public and by health professionals (doctors, pharmacists, nurses, etc.). Leader in France on many markets, the company has a clear desire to develop internationally which already represents 48% of its turnover. An ambition supported by a permanent approach of innovation, significant investments in research and development, production and clinical research to demonstrate the therapeutic efficiency of products. Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech | 3 | 485 |
 | C3M - Centre Méditerranéen de Médecine Moléculaire Centre de Recherche Médicale Inserm U1065 The Mediterranean Centre for Molecular Medicine (C3M) currently includes 13 joint INSERM/university teams, representing 160 people, that focus on three major research topics: Proliferation, Cellular Death, Differentiation and Cancer Biology of Host-microorganism interactions Metabolic diseases The diversity of research interests at C3M create an enriching work environment, facilitating interdisciplinary collaborations which benefit from complementary approaches and the expertise knowledge of each team. One of the current goals of the C3M is to expand via the integration of new research teams of the highest scientific quality, and whose research complements that of the existing teams. Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 6 | 63 |
 | IBDM Understanding development to understand pathologies The International Marseille Development Biology Institute (IBDM) brings together under a mixed supervision of the National Center for Scientific Research (CNRS) and Aix Marseille University (AMU) 21 International Research Teams that explore the field of development biology and pathologies associated with it. The research carried out at IBDM is intended to understand the mechanisms of training, organization and function of biological systems, as well as the nature of the disturbances at the origin of many pathologies such as congenital malformations, neuro-degenerative diseases and cancers. IBDM teams implement inter-disciplinary approaches in the fields of development, physiology, … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 6 | 83 |
 | Institute of NeuroPhysioPathology (INP) The Institute of NeuroPhysioPathology (INP-UMR7051) is a CNRS/AMU training & research center studying brain disorders The Institute of NeuroPhysioPathology (INP – UMR7051) was created on January 1st 2018 and is now directed by Pr François Devred. It is located in the Timone campus of the Medical Faculty of Marseille and is supported by Aix-Marseille University (AMU) and the CNRS. The INP brings together 11 teams totalling 150 people, half of whom have permanent positions (statutory staff). The main objectives of the Institute are to study on a fundamental level, through animal and cell models (including reprogramming / iPS cell modelling), … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 8 | 155 |
 | CRBS - Centre de recherche en biomédecine de Strasbourg CRBS - Strasbourg Biomedicine Research Center - @INSERMEST @Unistra | account piloted by @Léabussek The Strasbourg Biomedicine Research Center (CRBS), located on the Strasbourg Hospital campus, brings together ten scientific laboratories (University of Strasbourg and Inserm). With a multithematic vocation, he developed several research axes: • Neuroscience • Inflammation-immunity • Biomaterials • Medical genetics • Cancerology It also hosts the Alsace Medical Genetics Institute of Strasbourg University Hospitals (HUS). The CRBS works in connection with the Faculty of Medicine and welcomes 300 people. The objectives of the Center: Create a center of attractiveness on the Medicine-Hospital Campus by federating research … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 1 | 68 |
 | Ryvu Therapeutics Developing novel treatments at the forefront of oncology Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules directed at kinase, synthetic lethality, and immuno-oncology targets. Ryvu’s most advanced programs are RVU120 - a selective CDK8/CDK19 kinase inhibitor with potential for the treatment of hematological malignancies and solid tumors currently in Phase I clinical development for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II … 4 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 248 |
 | Serna Bio Mapping the druggable transcriptome An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood and interrogated, the field of RNA-targeted drugs is relatively new and the properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed. At Serna Bio [previously Ladder Therapeutics] we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class … 12 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 15 |
 | RangeMe Where product discovery starts. RangeMe is the leading online product discovery, sourcing, and purchasing platform that helps buyers and suppliers from around the world discover, connect, transact, and grow their businesses with ease. RangeMe enables retail buyers to efficiently discover and purchase products while empowering suppliers to manage, showcase, and grow their brands with the tools, insights, and services they need. Retail Buyers, Baby, Skincare, Beauty, Food, Beverage, Home, Office, Healthcare, Sports, Toys, Games, Suppliers and Manufacturers, and Consumer Goods / Products Type: Startup Activities: healthtech biotech deeptech fashtech games kidtech Technologies: SaaS | 10 | 49 |
 | Foghorn Therapeutics Inc. Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 128 |
 | Paradigm4 Scale your science, not your spend. Tap Paradigm4's REVEAL tech-enabled biomedical analytics platform and services. Paradigm4 is a platform-enabled biomedical analytics company catalyzing Life Sciences discovery and validation. Our REVEALTM biomedical analytics platform provides a unified environment for scientific data management, massively scalable computing, biomedical analytics, and AI-driven research, enabling users to fully leverage complex, multimodal datasets. Our flexFS filesystem enables users to scale their science, not their spend for secondary and tertiary analytics workflows to cryoEM data storage. Paradigm4’s long-standing partnerships and customer renewals underscore the platform's proven scientific and business value in accelerating drug discovery and precision medicine. … 16 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics IoT | 7 | 28 |
 | Sio Gene Therapies Pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases. Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development … 29 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 29 |
 |  OvaScience OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 8 |
 | Scene Health Breakthrough medication support for better health. Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Our 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivational content, we bring healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Our mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. We make it fun for patients to stay on … 5 similar entities Type: Startup Activities: healthtech deeptech biotech | 10 | 69 |
 | HueDx Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests HueDx is a Rapid, Quantitative, Assay-based (RQA) test development and launch platform that eliminates the need to develop physical devices and software to launch an RQA product. In doing so, HueDx makes the accessibility of launching flagship or complimentary diagnostics accessible to companies that would not normally consider the undertaking and veterans of the process. Type: Startup Activities: biotech deeptech Technologies: SaaS | 5 | 10 |
 | InquisitHealth is now Pyx Health Delivering better health 1-1 via an empathy-first Peer workforce Health plans, health systems, and employers leverage our Peer workforce (tech-enabled remote workforce of community health workers) to engage struggling patients (with empathy!) and help them address SDoH barriers, activate healthy behaviors and improve clinical outcomes. peer support, peer mentoring, community health workers, diabetes, asthma, prediabetes, sickle cell, hypertension, digital health, and coaching 86 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 37 |
 | Synthorx Inc Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a … 22 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 5 |
 | AssistRx Specialty therapy initiation and patient support company delivering informed access and improved outcomes. AssistRx has engineered the perfect blend of technology and talent to provide life sciences organizations with an advanced therapy initiation and patient support solution that improves patient uptake, visibility and outcomes. Our balanced approach streamlines enrollment, reduces therapy disruptions and provides real-time therapy visibility through an integrated solution—delivering the informed touchpoints that simplify a complex system to enable better results for today’s patients. The AssistRx solution includes therapy initiation and patient support, patient education and adherence, and therapy insights and analytics. We have built our entire platform … Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics | 7 | 841 |
 | Kinnos Pioneering color technology to create a safer world for all. Kinnos is a New York-based company that is pioneering color technology to revolutionize how we use disinfectants. Our flagship product, Highlight, is a patented and award-winning technology used by first responders, healthcare systems, and transit agencies to radically improve disinfection technique and quality. | 4 | 19 |
 | Biome Makers Inc. Decoding soil biology: Actionable soil intelligence for better agronomic decisions. Founded in California’s Silicon Valley in 2015, Biome Makers is one of the foremost global AgTech leaders, setting the standard in soil health with BeCrop® technology, the largest global taxonomic database of 24M microorganisms. Built on industry-leading AgTech expertise and driven by data and science, Biome Makers connect soil biology to agricultural decision-making to optimize farming practices and reverse the degradation of arable soils. With labs across the globe, customers on 6 continents, and 1M+ acres of land impacted, Biome Makers revitalizes soil functionality and agricultural sustainability worldwide. 10 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Data Analytics | 11 | 68 |
 | Candid Your digital platform for oral healthcare. ✨ At Candid, we believe dental professionals and their patients deserve more than what other clear aligner systems provide. That’s why we created CandidProTM: a total orthodontic solution that brings clinical support, connected treatment technology, and high-touch service into any practice. Health/Beauty, Cosmetic Dentistry, Cosmetics, Smile, Teeth , Orthodontics, and Clear Aligners Type: Startup Activities: biotech deeptech retail Technologies: SaaS | 1 | 311 |
 | HealthFactors, Inc. Smart therapy management improves clinical outcomes, makes data actionable, and improves care delivery. Health Factors, a medical technology company located in Minneapolis, is harnessing the power of Smart Therapy Management to change how respiratory care is delivered and to improve the patient and caregiver experience. Our core competencies include Medical Device Commercialization, Digital Health Solutions, and Therapeutic Transformation – all of which can be leveraged individually as service offerings to our industry partners or blended to create a Smart Therapy Management approach. Smart Therapy Management allows us to work efficiently in a value-based care arrangement to address unmet needs and … 89 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: IoT | 0 | 3 |
 | Boston Center for Memory Boston Center for Memory is an independent multi-specialty diagnostic and treatment center. The Boston Center for Memory provides evaluations of the highest quality for patients who have concerns about their memory in a timely manner, access to the latest treatments through participation in clinical trials, and support for the development of new treatments for Alzheimer’s disease and other causes of memory loss. Alzheimer's disease and Clinical Trials | 0 | 14 |
 | Recursion Decoding Biology to Radically Improve Lives Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 27 | 972 |
 | CareSignal® – Lightbeam's Deviceless Remote Patient Monitoring Deviceless Remote Patient Monitoring®: Scalable, evidence-based approach for improving clinical and financial outcomes. Lightbeam’s Deviceless Remote Patient Monitoring (RPM) solution, CareSignal, helps healthcare organizations and payers scale care management, touch more lives, and keep patients engaged. Self-guided Demo: https://try.caresignal.health Learn More: https://lightbeamhealth.com/deviceless-remote-patient-monitoring/ Self-guided Demo: https://try.caresignal.health Learn More: https://www.caresignal.health CareSignal's founding employees include: Blake Marggraff, Evan Huang, Joe McDonald, Jason Roche, and Emily Srygley. Mobile Health, Value-Based Care, Remote Patient Monitoring, Patient Engagement, Population Health, Chronic Disease Management, Deviceless Remote Patient Monitoring, Behavioral Health, Accountable Care Organizations, Medicare Advantage, Care Coordination, Medicaid, Payers, Provider Organizations, Health Equity, Social Determinants of Health, … Type: Startup Activities: healthtech biotech deeptech | 1 | 25 |
 | DNAsimple DNAsimple allows patients or anyone to contribute to scientific studies and provides a much-needed service for genomics labs - the opportunity to find study participants and obtain their DNA samples from various demographics for the purpose of their research studies. Through DNAsimple, scientists have a ready access to samples and sample donors get compensated for their study participation. genetics, genomics, biobanking, genetic research, saliva , DNA, DNA sample, microbiome, donor compensation, DNAsimple, healthcare research, and personalized medicine | 3 | 7 |
 | Elysium Health The company that believes everyone should benefit directly from compelling scientific research. Elysium Health’s mission is to solve the biggest challenges in health with science, to help people live healthier for longer. Elysium works directly with top scientists, clinicians and health professionals around the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium’s focus is to develop compounds found in nature that allow people … | 1 | 83 |
 | Verastem Oncology Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer … 19 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 125 |
 | Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also … Type: Startup Activities: biotech healthtech deeptech sporttech Technologies: SaaS | 1 | 9,917 |
 | Lyfebulb Connect People. Inspire Change. Impact Lives. Lyfebulb is a chronic disease focused, patient empowerment platform that connects patients, industry and investors to support user-driven innovation. Health, Diabetes, Chronic Disease, Wellness, Investing, Finance, Cancer, Inflammatory Bowel Disease, Entrepreneurship, and Chronic Illness 2 similar entities Type: Startup Activities: healthtech entrepreneurship fintech deeptech biotech Technologies: SaaS | 8 | 13 |
 | Lygos Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals 62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 73 |
 | Aris MD Inc. We are an immersive reality company taking augmented and virtual reality technology and enhancing surgery with it. We are using diagnostic images (MRI, CT, Xray, Ultrasound) and overlaying them over you, the patient during surgery. This gives the surgeon a guided map of your anatomy and your pathology or injury. This shows the surgeon where to cut and more importantly, where not to cut. Every persons anatomy differs not just on the outside but on the inside as well. My heart and liver are not located exactly where your heart and liver are. The surgeon has a general idea of … Type: Startup Activities: biotech deeptech edtech healthtech Technologies: VR | 9 | 4 |
 | LifeNome Inc. Award-winning precision health platform delivering personalized wellness solutions through genomics and deep science. LifeNome is a globally recognized leader transforming personalized health and longevity through cutting-edge AI, genomics, systems biology, and multi-omics science. Our precision health platform delivers tailored wellness and preventive care solutions for healthcare, insurance, pharmaceutical, nutrition, and fitness sectors worldwide. We empower partners to enhance health outcomes and lower costs with actionable, data-driven insights in key areas: Precision preventive health, including early disease risk detection and AI-driven intervention design Maternal and family health solutions focused on fertility, prenatal, and postpartum care Personalized nutrition and wellbeing based on … 57 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. | 17 | 16 |
 | Apic Bio, Inc. Committed to finding cures for patients with genetic diseases Apic Bio is committed to finding cures for patients with genetic diseases. | 1 | 6 |
 | Roivant Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical … 63 similar entities Type: Startup Activities: biotech deeptech | 10 | 258 |
 | Kernel Better data. Better brains. Enabling precision neuromedicine. Kernel's category-defining neuroimaging platform can be used to accelerate treatment development, improve patient outcomes, and reduce healthcare costs. 11 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 7 | 54 |
 | Virta Health Virta is the leader in diabetes reversal and sustainable weight loss with a nutrition first approach. We offer a proven, personalized nutrition program and expert support through technology to solve the health epidemic of our generation: diabetes and obesity. Virta empowers members with the tools and knowledge to sustain changes for a longer, healthier life. If you’re ready to transform lives and reinvent the standard of care, join us at Virta! We have opportunities for software engineers, health coaches, scientists, clinicians, and more. Visit https://www.virtahealth.com/careers to see our full list of open roles. See how Virta is transforming healthcare by … Type: Startup Activities: healthtech deeptech biotech Technologies: SaaS | 10 | 717 |
 | Portable Genomics, Inc. Portable Genomics Inc., La Jolla, CA, was created by Patrick Merel, PhD and a group of molecular biologists from Bordeaux, France, to design a mobile software platform for the use of genome data in personalized, predictive, preventive and participative medicine applications (P4TMMedicine). What makes Portable Genomics unique in the genomics space is a consumer-based approach to the visualization of genomic data. Portable Genomics platform, and IP, uses the digital music data structure to re-organise a genome data set and allows professionals and consumers to simply browse a genome in any MP3-compatible device from iPodsTM to mobile phones, from iWatchTM to … Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 0 | 1 |
 | EpigenCare Advancing Consumer Epigenetics EpigenCare is a privately held personal epigenomics and digital biotechnology company based in New York. The company offers a direct-to-consumer epigenetics test to assess the dynamic state of one's skin type and quality. Subsequently, capture of the dynamic quality allows for actionable results from the analysis report such that optimized product options are recommended to the consumer. skincare, blockchain, epigenetics, and personal genomics Type: Startup Activities: biotech deeptech Technologies: Blockchain/Cryptocurrency | 2 | 2 |
 | ApexQubit ApexQubit is a biotechnology company that is harnessing frontier technologies for better health for humanity. ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity. https://www.apexqubit.com/ #ArtificialIntelligence #BioTech #DeepTech #QuantumComputing #FrontierTech #B2B #Startup #RNA #DrugDesign #HealthTech Artificial Intelligence, Quantum Computing, Quantum Machine Learning, DeepTech, FrontierTech, BioTech, and Therapeutics 60 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 0 | 2 |
 | Decomer Technology We are developing a novel plant-based water-soluble and edible packaging material as well as products thereof Decomer Technology is developing a novel water-soluble and edible packaging material as well as products thereof. The material is plant-based, tasteless, transparent and hypoallergenic and can be used in food-, detergent-, pharmaceutical-, agricultural and other industries. We combine convenience and sustainability. 109 similar entities Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 1 | 2 |
 | Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … 74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 21 |
 | Human Longevity, Inc. Live a healthier, longer life. Human Longevity, Inc. TM (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 6 | 80 |
 | Imescia We develop an innovative subcutaneous formulation for anticancer highly potent API to unlock their full potential. IMESCIA is a preclinical-stage company developing a new formulation for anticancer highly potent APIs to unlock their full potential. Type: Startup Activities: deeptech biotech Technologies: SaaS | 2 | 2 |
 | DiogenX Targeting Beta Cell recovery in Diabetes DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France). Biotechnology and Diabetes 12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 19 |
 | Pepkon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families 134 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 8 |
 | Corteria Pharmaceuticals Interceptive therapies for the treatment of heart failure subpopulations Development of transformative therapies for the treatment of worsening and acute decompensated heart failure | 2 | 17 |
 | QUALIPLANTE Your best partner in plant health testing Qualiplante is a French start-up specialized in the development, the production and the commercialisation of innovative molecular diagnostic tools for the detection of plant diseases. Find the best tool for your plant health testing! Qualiplante offers to plant certification laboratories and all actors of agro-food industry, rapid and easy-to-use all-inclusive molecular kits that permit to detect, in a reliable and sensitive way, pathogens on crops. Validated by worldwide scientific experts, they include all the tools to perform a molecular analysis (ready-to-use master mix, positive and negative controls, analysis protocol). Thanks to the new … Type: Startup Activities: biotech deeptech Technologies: New Materials | 0 | 1 |
 | Sunogel Inc Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 | C4Hydro Expert in microorganism detection & enumeration in the environment C4Hydro is a biotechnology company based out of GRAND LUMINY TECHNOPOLE ZONE LUMINY 163 AVENUE DE LUMINY, MARSEILLE CEDEX 09, France. Biotechnologies, Bactériologie, Légionelle, Legionella pneumophila, Environnement, and Microorganismes 36 similar entities Type: Startup Activities: biotech deeptech cleantech greentech | 5 | 2 |
 | Intellisness Market Research, Competitive Intelligence, IP Intelligence Exclusively for the Life Sciences Community Specialised in life sciences, we help you make the best decisions by bringing you all the necessary market, scientific, and patent information. Our bias is clear. Our industry is structured around three pillars: science, markets, and industrial property. To only take one side of this trilogy into account can lead to erroneous conclusions. It’s for this reason that we’ve created a company capable of integrating those three dimensions. Our Scientific Committee is one example. Even though we invest heavily in technologies such as datamining, databases, and other tools … 47 similar entities Type: Startup Activities: biotech deeptech martech legaltech Technologies: Data Analytics | 0 | 1 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 13 |
 | In-Spir Olfactory branding. Improve comfort and well-being in your spaces. Natural and organic perfume diffuser 🇫🇷 In-SPIR, olfactory branding. Give new dimensions to your spaces thanks to the olfactory, our most emotional sense. Improve the well-being and comfort of your customers, employees and patients. Natural and organic perfumes for responsible experience. Connected and professional broadcasters for an extraordinary experience. We help you create your olfactory identity to strengthen your brand image in your shop, business, living room. Add a Zen atmosphere to your hair salon, beauty. Reduce the anxiety of your patients in the waiting room in a medical office vote. … Type: Startup Activities: biotech healthtech deeptech proptech Technologies: IoT Bio sourced materials | 4 | 1 |
 | Cure51 We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 12 | 47 |
 | ONCOMECA Early diagnosis of skin cancers has never been that easy! ONCOMECA is a class IIb medical device according to the EU regulation 2017/745. Our technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 90% reliable technology! 8 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 1 |
 | ViroScan3D Solutions Personnalisées de Génomique ViroScan3D is a service provider in genomic and micro-genomic located in Lyon. We have ten year experience in genome scale analyses from sample preparation to data analysis. During those years we have developed specific processes dedicated to complex samples (low quality and quantity samples). We propose our services for -Molecular broad spectrum identification of infectious agents, new agents, resistance mutants by whole genome sequencing of viruses and microorganisms (bacteria, yeast, fungi, etc.) -Analysis of complex populations using the metagenome, virome, bacteriome approach to identify the different agents in the population and their proportions -The identification of … 7 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics Synthetic Biology | 0 | 2 |
 | Atamyo Therapeutics Changing lives of neuromuscular patients with gene therapy. Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD). The name of the company is derived from two words: Celtic Atao which means “Always” or “Forever” and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 4 |
 | Generare Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology 98 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 8 | 21 |
 | LiMM Therapeutics LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 4 |
 | BOO$TER health Booster Health is a crowdfunding platform for the service of innovative health, living and well-being companies, specializing in fundraising between € 200,000 and € 1 million. Booster Health's goal: to allow a simpler and direct investment in French start-ups and SMEs in the health, living and well-being. We select, analyze and negotiate the best conditions of entry to the capital of these companies to facilitate the investment procedure. The Booster Health platform offers a financing solution far from the traditional circuit and creates a new investor - business relationship. In order to contribute to the development of a new financing … Type: Incubators & VCs Startup Activities: fintech healthtech deeptech biotech Technologies: SaaS | 0 | 0 |
 | EYEVENSYS We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection technology, which uses electroporation to deliver plasmids coding for therapeutic proteins in the eye. EyeCET is safe and non-viral, and it enables the ciliary muscle cells to sustainably produce therapeutic proteins locally. Eyevensys believes its EyeCET technology can improve short and long-term therapeutic outcomes, greatly enhancing patient compliance and significantly … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 8 |